iTeos Therapeutics, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
35.00 |
-8.21 |
6.75 |
76.31 |
97.16 |
151.44 |
| Przychód Δ r/r |
0.00% |
-123.46% |
-182.21% |
1030.60% |
27.32% |
55.87% |
| Przychód (min) |
35.00 |
-8.21 |
6.75 |
76.31 |
97.16 |
151.44 |
| Przychód (max) |
35.00 |
-8.21 |
6.75 |
76.31 |
97.16 |
151.44 |
| EBITDA (średnia) |
2.10 |
-0.49 |
0.41 |
4.58 |
5.83 |
9.09 |
| EBIT (średnia) |
2.07 |
-0.48 |
0.40 |
4.51 |
5.74 |
8.94 |
| EBIT % |
5.90% |
5.90% |
5.90% |
5.90% |
5.90% |
5.90% |
| Zysk netto (średni) |
-130.81 |
-146.19 |
-65.49 |
-135.60 |
-115.76 |
-101.79 |
| Zysk netto % |
-373.75% |
1780.76% |
-970.30% |
-177.71% |
-119.15% |
-67.22% |
| EPS (średnia) |
-3.15 |
-3.61 |
-1.62 |
-2.95 |
-2.86 |
-2.52 |
| Liczba analityków (Przychody) |
4 |
3 |
5 |
4 |
2 |
3 |
| Liczba analityków (EPS) |
4 |
3 |
3 |
2 |
1 |
1 |
| symbol |
ITOS |
ITOS |
ITOS |
ITOS |
ITOS |
ITOS |